Moreover, such platelet-derived microparticles with CD41+ and annexin V+ variated diurnally, increasing from morning and reaching their peak levels in the afternoon [26], suggesting a more complicated link between platelet activation and the risk of CVD in patients with OSA. The gene discussed is ANXA5; the disease is obstructive sleep apnea syndrome.